Similar articles

• The safety and cost-effectiveness of low osmolar contrast media.

  Proudfoot AD. Proudfoot AD. Med J Aust. 1991 Jul 15;155(2):136. Med J Aust. 1991. PMID: 1906974 No abstract available.
• The safety and cost-effectiveness of low osmolar contrast media.

  Benness GT. Benness GT. Med J Aust. 1991 Nov 4;155(9):646-8. Med J Aust. 1991. PMID: 1943970 Review. No abstract available.
• Intravenous contrast media: use and associated mortality.

  Cashman JD, McCredie J, Henry DA. Cashman JD, et al. Med J Aust. 1991 Nov 4;155(9):618-23. Med J Aust. 1991. PMID: 1943961
• Nonionic low-osmolar contrast media have no impact on major adverse cardiac events in patients undergoing coronary stenting with appropriate antiplatelet therapy.

  Danzi GB, Capuano C, Sesana M, Predolini S, Baglini R. Danzi GB, et al. Catheter Cardiovasc Interv. 2003 Dec;60(4):477-82. doi: 10.1002/ccd.10670. Catheter Cardiovasc Interv. 2003. PMID: 14624424 Clinical Trial.
• Iodinated radiographic contrast media: comparison of low-osmolar with conventional ionic agents [corrected].

  Rubin JD, Cohan RH. Rubin JD, et al. Curr Opin Radiol. 1991 Oct;3(5):637-45. Curr Opin Radiol. 1991. PMID: 1931499 Review.